Literature DB >> 35023023

Calorie restriction changes lipidomic profiles and maintains mitochondrial function and redox balance during isoproterenol-induced cardiac hypertrophy.

Cícera Edna Barbosa David1, Aline Maria Brito Lucas1, Pedro Lourenzo Oliveira Cunha1, Yuana Ivia Ponte Viana1, Marcos Yukio Yoshinaga2, Sayuri Miyamoto2, Adriano Brito Chaves Filho2, Anna Lídia Nunes Varela1, Alicia Juliana Kowaltowski2, Heberty Tarso Facundo3.   

Abstract

Typically, healthy cardiac tissue utilizes more fat than any other organ. Cardiac hypertrophy induces a metabolic shift leading to a preferential consumption of glucose over fatty acids to support the high energetic demand. Calorie restriction is a dietary procedure that induces health benefits and lifespan extension in many organisms. Given the beneficial effects of calorie restriction, we hypothesized that calorie restriction prevents cardiac hypertrophy, lipid content changes, mitochondrial and redox dysregulation. Strikingly, calorie restriction reversed isoproterenol-induced cardiac hypertrophy. Isolated mitochondria from hypertrophic hearts produced significantly higher levels of succinate-driven H2O2 production, which was blocked by calorie restriction. Cardiac hypertrophy lowered mitochondrial respiratory control ratios, and decreased superoxide dismutase and glutathione peroxidase levels. These effects were also prevented by calorie restriction. We performed lipidomic profiling to gain insights into how calorie restriction could interfere with the metabolic changes induced by cardiac hypertrophy. Calorie restriction protected against the consumption of several triglycerides (TGs) linked to unsaturated fatty acids. Also, this dietary procedure protected against the accumulation of TGs containing saturated fatty acids observed in hypertrophic samples. Cardiac hypertrophy induced an increase in ceramides, phosphoethanolamines, and acylcarnitines (12:0, 14:0, 16:0, and 18:0). These were all reversed by calorie restriction. Altogether, our data demonstrate that hypertrophy changes the cardiac lipidome, causes mitochondrial disturbances, and oxidative stress. These changes are prevented (at least partially) by calorie restriction intervention in vivo. This study uncovers the potential for calorie restriction to become a new therapeutic intervention against cardiac hypertrophy, and mechanisms in which it acts.
© 2021. The Author(s) under exclusive licence to University of Navarra.

Entities:  

Keywords:  Antioxidants; Calorie restriction; Cardiac hypertrophy; Free radicals; Lipidome; Mitochondria

Mesh:

Substances:

Year:  2022        PMID: 35023023     DOI: 10.1007/s13105-021-00863-4

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  27 in total

1.  Diazoxide prevents reactive oxygen species and mitochondrial damage, leading to anti-hypertrophic effects.

Authors:  Aline M Lucas; Francisco R Caldas; Amanda P da Silva; Maximiano M Ventura; Iago M Leite; Ana B Filgueiras; Claúdio G L Silva; Alicia J Kowaltowski; Heberty T Facundo
Journal:  Chem Biol Interact       Date:  2016-11-17       Impact factor: 5.192

2.  Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.

Authors:  Jessica M Ellis; Shannon M Mentock; Michael A Depetrillo; Timothy R Koves; Shiraj Sen; Steven M Watkins; Deborah M Muoio; Gary W Cline; Heinrich Taegtmeyer; Gerald I Shulman; Monte S Willis; Rosalind A Coleman
Journal:  Mol Cell Biol       Date:  2011-01-18       Impact factor: 4.272

3.  Functional changes induced by caloric restriction in cardiac and skeletal muscle mitochondria.

Authors:  Julian David C Serna; Camille C Caldeira da Silva; Alicia J Kowaltowski
Journal:  J Bioenerg Biomembr       Date:  2020-05-27       Impact factor: 2.945

4.  Calorie restriction attenuates hypertrophy-induced redox imbalance and mitochondrial ATP-sensitive K+ channel repression.

Authors:  Cicera Edna Barbosa David; Aline Maria Brito Lucas; Maria Thalyne Silva Araújo; Beatriz Neves Coelho; Juarez Braga Soares Neto; Bruna Raysa Campos Portela; Anna Lídia Nunes Varela; Alicia J Kowaltowski; Heberty T Facundo
Journal:  J Nutr Biochem       Date:  2018-09-05       Impact factor: 6.048

5.  The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover.

Authors:  J Michael O'Donnell; Aaron D Fields; Natalia Sorokina; E Douglas Lewandowski
Journal:  J Mol Cell Cardiol       Date:  2007-11-24       Impact factor: 5.000

6.  Long-chain monounsaturated Fatty acids and incidence of congestive heart failure in 2 prospective cohorts.

Authors:  Fumiaki Imamura; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Lyn M Steffen; Aaron R Folsom; David S Siscovick; Dariush Mozaffarian
Journal:  Circulation       Date:  2013-03-13       Impact factor: 29.690

7.  Omega-3 as well as caloric restriction prevent the age-related modifications of cholesterol metabolism.

Authors:  Chiara Martini; Valentina Pallottini; Elisabetta De Marinis; Maria Marino; Gabriella Cavallini; Alessio Donati; Sara Straniero; Anna Trentalance
Journal:  Mech Ageing Dev       Date:  2008-09-26       Impact factor: 5.432

8.  Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure.

Authors:  Aalap Chokshi; Konstantinos Drosatos; Faisal H Cheema; Ruiping Ji; Tuba Khawaja; Shuiqing Yu; Tomoko Kato; Raffay Khan; Hiroo Takayama; Ralph Knöll; Hendrik Milting; Christine S Chung; Ulrich Jorde; Yoshifumi Naka; Donna M Mancini; Ira J Goldberg; P Christian Schulze
Journal:  Circulation       Date:  2012-05-14       Impact factor: 29.690

9.  ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1.

Authors:  Guenter Haemmerle; Tarek Moustafa; Gerald Woelkart; Sabrina Büttner; Albrecht Schmidt; Tineke van de Weijer; Matthijs Hesselink; Doris Jaeger; Petra C Kienesberger; Kathrin Zierler; Renate Schreiber; Thomas Eichmann; Dagmar Kolb; Petra Kotzbeck; Martina Schweiger; Manju Kumari; Sandra Eder; Gabriele Schoiswohl; Nuttaporn Wongsiriroj; Nina M Pollak; Franz P W Radner; Karina Preiss-Landl; Thomas Kolbe; Thomas Rülicke; Burkert Pieske; Michael Trauner; Achim Lass; Robert Zimmermann; Gerald Hoefler; Saverio Cinti; Erin E Kershaw; Patrick Schrauwen; Frank Madeo; Bernd Mayer; Rudolf Zechner
Journal:  Nat Med       Date:  2011-08-21       Impact factor: 87.241

10.  Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study.

Authors:  Christin Stegemann; Raimund Pechlaner; Peter Willeit; Sarah R Langley; Massimo Mangino; Ursula Mayr; Cristina Menni; Alireza Moayyeri; Peter Santer; Gregor Rungger; Tim D Spector; Johann Willeit; Stefan Kiechl; Manuel Mayr
Journal:  Circulation       Date:  2014-03-12       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.